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Abstract
Background: There is considerable interest in estimating the causal effect of a range of
maternal environmental exposures on offspring health-related outcomes. Previous
attempts to do this using Mendelian randomization methodologies have been hampered
by the paucity of epidemiological cohorts with large numbers of genotyped mother–
offspring pairs.
Methods: We describe a new statistical model that we have created which can be used
to estimate the effect of maternal genotypes on offspring outcomes conditional on off-
spring genotype, using both individual-level and summary-results data, even when the
extent of sample overlap is unknown.
Results: We describe how the estimates obtained from our method can subsequently be
used in large-scale two-sample Mendelian randomization studies to investigate the
causal effect of maternal environmental exposures on offspring outcomes. This includes
studies that aim to assess the causal effect of in utero exposures related to fetal growth
restriction on future risk of disease in offspring. We illustrate our framework using exam-
ples related to offspring birthweight and cardiometabolic disease, although the general
principles we espouse are relevant for many other offspring phenotypes.
Conclusions: We advocate for the establishment of large-scale international genetics
consortia that are focused on the identification of maternal genetic effects and commit-
ted to the public sharing of genome-wide summary-results data from such efforts. This
information will facilitate the application of powerful two-sample Mendelian randomiza-
tion studies of maternal exposures and offspring outcomes.
VC The Author(s) 2019. Published by Oxford University Press on behalf of the International Epidemiological Association. 1
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Introduction
There is considerable interest in elucidating the causal effect
of maternal environmental exposures on offspring out-
comes. However, traditional observational epidemiological
studies are prone to confounding, bias and reverse causality.
Mendelian randomization (MR) is an epidemiological
method that was developed to estimate the causal effect of
environmental exposures on medically relevant outcomes.1
Recently, several studies have attempted to use MR to inves-
tigate the causal effect of maternal environmental exposures
on offspring outcomes.2,3 However, most of these studies
have been performed in relatively small samples of geno-
typed mother–offspring pairs because offspring genotypes
are needed to prevent violation of the assumptions underly-
ing MR. This has consequently limited the statistical power,
utility and broader application of the MR method in investi-
gating the causal effect of maternal environmental expo-
sures on offspring outcomes.
In this manuscript, we describe a statistical method based
on structural equation modelling that we have recently de-
veloped to partition genetic effects on offspring phenotypes
into maternal and offspring components.4 We discuss how
this partitioning could be used to facilitate large-scale two-
sample MR studies of maternal exposures and offspring out-
comes in different samples of individuals, maximizing sam-
ple size and obviating the requirement of individual-level
genotyped mother–offspring pairs. Within this context, we
show how the recent identification of genetic loci that exert
maternal effects on offspring birthweight5 provides an op-
portunity to assess the causal effect of in utero exposures re-
lated to fetal growth on offspring outcomes using this
method. We illustrate our methods using an example involv-
ing susceptibility to type 2 diabetes and offspring birth-
weight. Our methods have broad applicability to
investigating hypotheses involving the Developmental
Origins of Health and Disease (DOHaD).6 Finally, we advo-
cate for the establishment of large-scale genetics consortia
whose remit is to identify maternal genetic effects and utilize
this information to elucidate the role of maternal environ-
mental factors on offspring outcomes via MR using the
methods that we espouse in this manuscript.
Partitioning genetic effects at individual loci
into maternal and offspring components
The resolution of genetic effects into maternal and off-
spring components is important because it not only pro-
vides meaningful insights into the mechanism through
which genotypes exert their effects on offspring pheno-
types, but it can also be leveraged for a number of informa-
tive downstream analyses including MR.1,4,7 Traditionally,
in human genetic association studies, the estimation of ma-
ternal genetic effects on offspring phenotypes has been
achieved through conditional genetic association analysis
of genotyped mother–offspring pairs. For example, one
regresses offspring phenotype on maternal genotype whilst
controlling for the possible confounding influences of the
offspring’s genotype:
Yi ¼ aþ bo  oSNPi þ bm mSNPi þ ei (1)
where Yi and oSNPi refer to the (offspring) phenotype and
SNP genotype of the ith individual, mSNPi is the genotype
of the individual’s mother at the same locus, bo and bm the
estimated offspring and maternal effects of the SNP, a is an
intercept and ei a normally distributed residual term.
However, a problem with this simple approach is that
there is a paucity of cohorts worldwide with genome-wide
association study (GWAS) data on both mothers and their
offspring. Additionally, loci influencing complex traits in
the offspring are typically of small effect and, since mater-
nal and offspring genotypes are highly correlated, power is
often low to definitively partition genetic effects into ma-
ternal and offspring components. For example, in a recent
Key Messages
• Statistical methods exist for partitioning genetic effects at single loci into maternal and offspring genetic components.
• Estimates of maternal genetic effects obtained from these methods can be used in large-scale two-sample Mendelian
randomization studies to investigate the causal effect of maternal environmental exposures on offspring outcomes.
• Two-sample Mendelian randomization studies can also be used to assess the causal effect of in utero exposures re-
lated to fetal growth on future risk of disease in offspring.
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study of offspring birthweight, we initially attempted to
partition the genetic effect at 58 autosomal genome-wide
significant birthweight SNPs into maternal and offspring
components using simple conditional linear regression in
some of the largest genotyped cohorts of mother–offspring
pairs that were available at the time (total N¼ 12 909).
However, we were unable to resolve these effects defini-
tively at nearly all of the birthweight loci.8
Recently, we developed a new statistical model based on
the mathematical technique of structural equation model-
ling, which has allowed us to estimate maternal and off-
spring effects on birthweight utilizing data from the large
UK Biobank Study.4,9 A key realization was that the UK
Biobank Study contains self-reported information not only
on individuals’ own birthweight, but also (in the case of
females) on the birthweight of their first-born offspring, and
this makes it possible to resolve both maternal and offspring
effects on birthweight in the cohort. Figure 1 illustrates the
mathematical features of our structural equation model
(SEM) in the form of a path diagram. One-headed arrows
represent causal paths and two-headed arrows correlational
relationships. The three observed variables (in squares) de-
note the birthweight of a UK Biobank individual (BW), the
birthweight of their offspring (BWO) and their own geno-
type (SNP). The latent unobserved variables (in circles) rep-
resent the genotypes of the individual’s mother (their
offspring’s grandmother; GG) and the genotype of the indi-
vidual’s first-born offspring (GO). The total variance of the
latent genotypes for the individual’s mother (GG) and off-
spring (GO) and for the observed SNP variable are all set to
U [i.e. variance(GG)¼U, variance(SNP)¼ 0.75Uþ 0.25U,
variance(GO)¼ 0.75Uþ 0.25U, as can be verified by path
analysis/covariance algebra], which is estimated from the
data. According to quantitative genetics theory, the causal
path between the individual’s own genotype and both their
mother and offspring’s latent genotype is set to 0.5. The bm
and bo path coefficients refer to maternal and offspring ge-
netic effects on birthweight, respectively, and are equivalent
to the coefficients estimated using the conditional linear
model in Equation (1). The residual error terms for the
birthweight of the individual and their offspring are repre-
sented by E and EO, respectively, and the variance of both
these terms is estimated in the SEM. The covariance be-
tween the error terms is denoted by q. Models can be fit by
maximum likelihood using the OpenMx software pack-
age.10 We have included an example R code that imple-
ments this SEM in the Supplementary Materials, available
as Supplementary data at IJE online, of this manuscript.
Our approach is flexible in that the results from ‘single-
tons’ can be incorporated into the analysis (i.e. genotyped
individuals who have either their own or their offspring’s
birthweight available) and the results from the SEM can be
meta-analysed with results from conditional genetic associ-
ation analyses of genotyped mother–offspring pairs.
Importantly, our method can incorporate both individual-
level genotype data (e.g. from the UK Biobank Study) and
summary-level GWAS results data from other research
groups and publicly available websites. The result is an ex-
tremely large, powerful, combined dataset for the estima-
tion of maternal and offspring effects on birthweight.
Additionally, when the model is applied across the genome
(e.g. for locus-detection purposes), it can increase the
power to detect variants that have opposing maternal and
offspring effects on birthweight that may not otherwise be
apparent.4
We have recently described the statistical properties of
our approach, demonstrated that it yields unbiased estimates
of maternal and offspring genetic effects on birthweight,
gives similar answers to conditional genetic association anal-
yses of genotyped mother–offspring pairs and has low sensi-
tivity to random measurement error.4 Additionally,
asymptotic power calculations using the ‘Maternal and
Offspring Genetic Effects Power Calculator’11 (http://evan
Figure 1. Structural equation model (SEM) used to estimate maternal
and offspring genetic effects on birthweight. The three observed varia-
bles (in squares) denote the birthweight of a UK Biobank individual
(BW), the birthweight of their offspring (BWO) and their own genotype
(SNP). The latent unobserved variables (in circles) represent the geno-
types of the individual’s mother (their offspring’s grandmother; GG) and
the genotype of the individual’s first offspring (GO). The total variance
of the latent genotypes for the individual’s mother (GG) and offspring
(GO) and for the observed SNP variable are set to U and are estimated
from the data. The causal path between the individual’s own genotype
and both their mother and offspring’s latent genotype is set to 0.5. The
bm and bo path coefficients refer to maternal and offspring genetic
effects on birthweight, respectively. The residual error terms for the
birthweight of the individual and their offspring are represented by E
and EO, respectively, and the variance of both these terms is estimated
in the structural equation model. The covariance between the error
terms is denoted by q. The model can be modified easily to include ob-
served genotypes and/or the absence of one of the birthweight
phenotypes.
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sgroup.di.uq.edu.au/MGPC/) indicate that, whilst our ap-
proach is less powerful than similar-sized samples of geno-
typed mother–offspring pairs, the two study designs have
similar power when the residual correlation between mater-
nal and offspring phenotypes (q in Figure 1) approaches
0.5.11 Figure 2 compares the asymptotic power to detect ma-
ternal effects on birthweight (assuming a residual correlation
between maternal and offspring phenotypes of 0.2) using
three different study designs. In the first study design, 50 000
genotyped mother–offspring pairs are used in a SEM asymp-
totically equivalent to a conditional linear model. Through
our contacts within the Early Growth Genetics (EGG) con-
sortium, we have estimated that 50 000 mother–offspring
pairs with genome-wide SNP data would currently be avail-
able worldwide for meta-analysis. In the second study de-
sign, we use the SEM described in Figure 1 with the number
of unrelated individuals currently available through either
the UK Biobank Study or EGG consortium who have data
on both their own and their offspring’s birthweight
(N¼ 85 518), their own birthweight only (N¼ 178 980) or
their offspring’s birthweight only (N¼ 93 842). In the third
design, we combine the previous two data sources and con-
duct the SEM described in Figure 1. Figure 2 illustrates the
advantage in power obtained by using the large combined
sample from the UK Biobank Study and the EGG consor-
tium, including individuals with both maternal and offspring
phenotypes and singleton individuals with only one pheno-
type, compared with the power obtained from our estimate
of the current number of genotyped mother–offspring pairs
that are available across the world. However, the power can
be increased dramatically by including all individuals to-
gether in the analysis.
To further illustrate the utility of our method, we ap-
plied our SEM to 58 known autosomal SNPs for birth-
weight using data from the interim release of the UK
Biobank Study.8 Figure 3 displays the estimated maternal
(y-axis) and offspring (x-axis) genetic effects on birth-
weight at each of these loci. Figure 3 shows that most loci
influence birthweight primarily through the offspring ge-
nome, which was anticipated, as the loci were initially
identified in a GWAS of the individual’s own birthweight.
However, there is a subset of SNPs that exert their effects
predominantly through the mother’s genome (e.g.
MTNR1B, EBF1, ACTL9) and at least six loci that exhibit
maternal and offspring effects in opposite directions.
Interestingly, the loci that manifest opposing effects
through maternal and offspring genomes include the type 2
diabetes-associated loci HHEX-IDE, CDKAL1 and
ADCY5. Our results are consistent not only with smaller
and less powerful conditional regressions in genotyped
mother–offspring pairs,4,8 but also with examples of op-
posing maternal and offspring contributions on the birth-
weight of rare mutations influencing insulin secretion and
glucose tolerance, upon which the Fetal Insulin Hypothesis
was based, such as those in the GCK gene.12
Figure 2. Power to detect maternal effects on birthweight as a function
of variance explained. We assume a residual correlation of 0.2 between
own birthweight and offspring birthweight and that the same locus
exerts a maternal effect only. We compare power for N¼ 50 000 geno-
typed mother–offspring pairs (i.e. which is an estimate of the current
number of available genotyped mother–offspring pairs worldwide that
could be conceivably used for these analyses) with the current number
of individuals contributing to the UK Biobank and Early Growth
Genetics Consortium Analysis of birthweight (i.e. number of genotyped
individuals who have data on their own birthweight and their off-
spring’s birthweight N¼ 85 518; number of genotyped individuals who
have data on their own birthweight only N¼ 178 980; number of geno-
typed individuals who have data on their offspring’s birthweight only
N¼ 93 842) at genome-wide significance (a¼ 5 10–8). Asymptotic
power calculations were performed using the ‘Maternal and Offspring
Genetic Effects Power Calculator’ (Moen et al., 201911).
Figure 3. Estimated maternal and offspring genetic effects on birthweight
for 58 autosomal SNPs robustly associated with birthweight. Squares
highlight the subset of SNPs that exert their effects predominantly
through the mother’s genome (Pmaternal< 0.001 and Poffspring> 0.5).
Triangles highlight the subset of SNPs with both maternal and offspring
genetic effects operating in opposite directions (Pmaternal< 0.05 and
Poffspring<0.05); the SNPs with their gene names are those previously as-
sociated with type 2 diabetes. The figure is based on data presented in
Warrington et al. (2018).4
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Whilst we have discussed our method within the context
of offspring birthweight, there is no reason why the same or
similar methods could not be applied to understand the ge-
netic basis of other offspring phenotypes. Many offspring
traits are thought to be influenced by maternal phenotypes13
and, indeed, maternal effects at specific genetic loci have
been demonstrated in the case of offspring birthweight,5 off-
spring gestational age14 and offspring atopic dermatitis,15
amongst others. However, a major practical challenge in
detecting/demonstrating maternal genetic effects is the pau-
city of large-scale cohorts with genome-wide maternal geno-
types and offspring phenotypes. One way of facilitating the
discovery of maternal genetics effects would be for research-
ers to publish complete summary GWAS results of maternal
genotypes and offspring phenotypes, conditional upon off-
spring genotype, on publicly available websites. However,
performing conditional association analyses across the ge-
nome is computationally intensive and may be difficult for
some researchers to implement. A simpler alternative might
be for investigators to deposit unconditional GWAS meta-
analyses documenting the association between maternal gen-
otypes and offspring phenotypes. These summary results
could then be combined with GWAS of offspring genotype
and phenotype in a SEM to generate unbiased estimates of
maternal and offspring genetic effects on offspring pheno-
types—even when the degree of sample overlap is unknown.
Given the phenotypic correlation between maternal and off-
spring phenotypes, appropriate standard errors could then be
obtained in these models by estimating the degree of sample
overlap using bivariate linkage disequilibrium (LD) score re-
gression16 and weighting the SEM likelihood appropriately.
In order to illustrate this potential, Figure 4 compares esti-
mates of maternal (and offspring) genetic effects on birth-
weight at 51 known autosomal birthweight loci (with minor
allele frequency greater than 1%) using summary-results
GWAS data from the UK Biobank Study at various degrees
of sample overlap (i.e. the same individual contributes to
both the maternal and offspring GWAS summary-results
data on birthweight). The column axis displays estimates
(and their standard errors) from summary-results data when
the degree of sample overlap is known. The second column
displays the same information from summary-results data
when the degree of sample overlap is unknown and has to be
estimated using bivariate LD score regression.16 Provided the
phenotypic correlation between maternal and offspring birth-
weight is specified relatively accurately (see Figure 4), esti-
mates of maternal and offspring SNP effects and their
standard errors are the same across the two approaches. It is
likely that similar results could also be obtained using other
conditional analysis strategies.17,18
Using two-sample MR studies to analyse the
causal effect of maternal environmental
exposures on offspring phenotypes
Once genetic effects on offspring phenotypes have been
partitioned into maternal and offspring components, the
Figure 4. Effect sizes and standard errors for 51 autosomal birthweight-associated SNPs, which have a minor allele frequency greater than 1%, esti-
mated from a structural equation model using covariance matrices derived from GWAS summary results of own birthweight and offspring birth-
weight from the UK Biobank Study. Both GWASs used z-scores of birthweight in a subset of unrelated Europeans, after adjusting for ancestry
informative principal components and sex for the individual’s own birthweight (sex was not available for the birthweight of the first child in the UK
Biobank Study). The x-axis presents results when the sample overlap is known and the y-axis presents results when the sample overlap is estimated
using bivariate LD score regression. The phenotypic correlation between own birthweight and offspring birthweight was assumed to be 0.23 (misspe-
cifying this correlation by small amounts i.e. q¼ 0.1–0.3 did not appear to influence estimates nor their standard errors for these data—results not
shown).
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resulting estimates can be utilized in a variety of informa-
tive downstream analyses. In this section, we argue that
the availability of maternal effect estimates on offspring
phenotypes allows us to estimate the causal effect of mater-
nal environmental exposures on offspring outcomes via
two-sample MR19 in potentially large samples of
individuals.
MR is an epidemiological method that uses genetic var-
iants robustly associated with a modifiable environmental
exposure of interest to estimate the causal relationship be-
tween the exposure and a trait or disease of interest.1 In
the context of this manuscript, the relevant exposures are
maternal traits and exposures that might affect offspring
outcomes (especially whilst the offspring is in utero, but
the method is also relevant for evaluating post-natal mater-
nal influences on offspring phenotypes). Mendel’s Law of
Segregation ensures that genetic variants segregate ran-
domly and independently of environmental factors, whilst
Mendel’s Law of Independent Assortment suggests that the
genetic variants should also segregate independently of
other traits, provided certain conditions are met. This
means that genetic variants are less susceptible to con-
founding than the ‘traditional’ variables used in observa-
tional epidemiological studies.20 In other words, genetic
variants can be used to divide a study sample into sub-
groups, which differ systematically with respect to the ex-
posure of interest, but not with respect to confounding
factors. If groups defined by their genotypes also show dif-
ferences in their outcome, then, provided core assumptions
are met,21 this provides evidence that the exposure causally
influences the outcome. The basic MR framework has
been extended successfully to two-sample situations where
the SNP–exposure association is estimated in one sample
and the SNP–outcome association is measured in an-
other.19 This is important because it means that very pre-
cise estimates of the causal effect can be obtained by
utilizing publicly available GWAS summary-results data,
often using tens or hundreds of thousands of individuals.22
Although MR is a useful method for assessing causality,
there are a number of assumptions and potential complica-
tions that should be borne in mind that we have discussed
at length elsewhere.7,23,24 First, MR requires robust associ-
ation between genetic variants and the exposure of interest
[assumption (i) in Figure 5A]. Second, MR assumes that
the genetic variants used are uncorrelated with confound-
ers of the exposure–outcome relationship [assumption (ii)
in Figure 5A]. Mendel’s Laws of Segregation and
Independent Assortment provide assurance that this as-
sumption is likely to be valid and there is considerable em-
pirical evidence that this is indeed the case for many
genetic variants.20 Third, MR assumes that the genetic in-
strument is only potentially associated with the outcome
through the exposure of interest [assumption (iii) in
Figure 5A]. This assumption, also known as the exclusion
restriction criterion, precludes SNPs (or variants in LD
with them) that influence multiple phenotypic traits includ-
ing the exposure of interest through horizontal pleiotropy
and also have an association with the outcome that is not
mediated through the exposure of interest. It is widely
regarded that this final assumption is likely to be more
problematic for the validity of MR than the two previous
assumptions, although a number of different procedures
are available to detect and correct for horizontal pleiot-
ropy.24–29
MR has recently been used to examine the causal effect
of maternal environmental exposures on offspring out-
comes. Examples include the effect of maternal cardiome-
tabolic phenotypes2 and smoking3 on offspring
birthweight and maternal alcohol consumption during
pregnancy on offspring education.30 MR studies that at-
tempt to estimate the causal effect of maternal exposures
on offspring outcomes are subject to all the usual limita-
tions of MR studies. However, one complication specific
to estimating the causal effect of maternal environmental
Figure 5. Directed acyclic graphs illustrating the core assumptions un-
derlying Mendelian randomization. Assumption (i) requires robust as-
sociation between the genetic variants and the maternal exposure.
Assumption (ii) requires that the genetic variants are uncorrelated with
confounders. Assumption (iii) assumes that the genetic variants are
only potentially associated with the offspring outcome through the ma-
ternal exposure of interest. Offspring genetic variants violate assump-
tion (iii), as they allow a path to offspring outcome that is not through
the maternal exposure (iv). However, conditioning on offspring variants
(indicated by a box around offspring SNPs) blocks path (iv) and as-
sumption (iii) holds.
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exposures on offspring outcomes via MR is the fact that
maternal and offspring genotypes are correlated.
Consequently, any association between maternal genotype
and offspring outcome may in fact be mediated by off-
spring genotype (Figure 5B). One solution to this problem
is to statistically correct for offspring’s genotype by condi-
tioning on offspring genotype in the MR analysis.2,7 For
example, Tyrrell et al.2 have used MR in mother–offspring
pairs to show that higher maternal systolic blood pressure
is likely to be causal for low offspring birthweight after
conditioning on offspring genotype. However, there is a
dearth of cohorts that have genotyped mother–offspring
pairs, meaning that such analyses are likely to be
underpowered.
One potential way to increase the power of MR analy-
ses involving maternal exposures and offspring outcomes is
to utilize two-sample MR in potentially extremely large
samples of individuals.7,19 First, unbiased estimates of ma-
ternal genetic effects on the offspring phenotype could be
obtained, e.g. from the SEM in Figure 1. These effects rep-
resent the influence of maternal genotype on offspring out-
come with the effect of the offspring’s genotype removed.
These estimates could then be combined with SNP–expo-
sure estimates for the maternal exposures that the investi-
gator is interested in, in a two-sample MR framework. In
the case of offspring birthweight, the attractiveness of this
strategy lies in the fact that the entire UK Biobank Study
sample and data from the EGG consortium (and indeed
any other publicly available summary-results statistics and
large-scale cohorts) could be leveraged to estimate the as-
sociation between maternal genotypes and offspring birth-
weight. Simultaneously, the largest publicly available
GWAS meta-analysis could be used to estimate the associa-
tion between the same SNPs and the maternal exposures of
interest. The robustness of causal estimates, including to
the possibility of latent horizontal pleiotropy, can subse-
quently be investigated using sensitivity analyses including
MR Egger regression,25 weighted median MR,26 the MR
modal estimator,28 multivariable MR,29 random-effects
meta-analyses24 and tests of heterogeneity between the
causal-effect estimates derived from different SNPs.27
The two-sample MR procedure we advocate relies on the
assumption that the variants associated with the maternal
exposure of interest are also associated with these same
traits during the critical period of interest (e.g. during preg-
nancy) and also that it is this time point that is relevant in
terms of influencing the offspring phenotype. The same
assumptions are of course also made in one-sample MR
studies using genotyped mother–offspring pairs—the
critical difference being that, in the latter case, it may be
possible to investigate these assumptions empirically.7
For example, there is preliminary evidence to suggest that
genetic variants associated with cardiometabolic phenotypes
in the general population (i.e. men and women who are not
pregnant) are also associated with the same traits in mothers
during pregnancy, meaning that SNPs that proxy these traits
also proxy the exposures in pregnant women.2,31
In all the MR analyses we describe above, we assume
that maternal genotypes act additively on the maternal ex-
posure of interest; the absence of parent of origin effects
(e.g. from genetic imprinting); genetic non-additivity (in-
cluding genetic dominance and epistasis); no gene–gene in-
teraction between maternal, paternal and/or offspring
genotypes; and the absence of paternal genetic effects af-
fecting the offspring outcome at the same loci used in the
maternal–offspring analyses. Recent work from the
deCODE group and others13,32 has shown that offspring
phenotypes are influenced by untransmitted alleles from
both parents. The presence of paternal genetic effects at
the same loci used in the analysis will bias estimates of the
maternal and offspring genetic effects on the offspring out-
come (and consequently estimates of the causal effect of
the maternal and offspring exposures on offspring out-
come). This is probably more likely to be a problem where
the outcome phenotype is a more ‘visible’ lifestyle charac-
teristic, such as smoking, alcohol consumption, diet or
physical activity, which could subsequently influence the
offspring or that the offspring might mimic or be encour-
aged to adopt, than it is for something like a circulating
biomarker, such as fasting glucose or vitamin D. In order
to account for the effect of paternal genetic effects, pater-
nal genotypes at the same loci would need to be included
in the statistical model. Whilst this could be accomplished
relatively easily in the structural equation modelling frame-
work that we have espoused in this manuscript, doing so
might be difficult in practice because of the small numbers
of cohorts that have obtained genome-wide paternal geno-
type data on their participants. We have summarized some
of the potential issues/limitations specific to MR studies of
maternal exposures and offspring outcomes in Table 1.
Finally, we note that an alternative approach consisting
of fitting a multivariate model that includes maternal geno-
type, offspring genotype, maternal exposure and offspring
outcome (e.g. via multivariable MR29) would likely yield
similar causal estimates of the maternal exposure on the
offspring outcome to the framework that we espouse in
this manuscript. However, we emphasize that, regardless
of which approach is used, the important point is that both
methods are capable of generating and utilizing estimates
of the conditional effect of maternal genotype on offspring
phenotype in two-sample data, increasing the number of
individuals contributing to the analysis and statistical
power to detect the causal effect of maternal exposures on
offspring outcomes.
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Table 1. Potential limitations of MR studies of maternal exposures and offspring outcomes and suggestions of how to deal with
them. We do not list limitations that are endemic to all types of MR studies, but rather focus on issues that are specific to MR
studies of maternal exposures and offspring outcomes
Potential limitation Description Solution
Suitability of genetic variants to
proxy maternal environmental
exposure of interest
A key question is whether genetic variants identified
in GWAS of men and (non-pregnant) women are
appropriate instruments for the research question,
e.g. if the interest is on the effect of maternal
environmental exposures during pregnancy on
offspring outcomes, is it appropriate to use SNP
effects from a GWAS of the environmental
exposure in another population?
Where possible utilize estimates of the
association of SNPs with maternal
exposures in population of interest
during time period of interest
Timing of maternal exposure Since an individual’s genetic variants are present
from conception, causal estimates derived from
MR studies are often thought to represent life-
long effects of the environmental exposure.
Interpretation of these estimates may be difficult if
the investigator is interested in the effect of the
maternal exposure during a particular time period
(e.g. prenatal exposures)
See above.
Examining the causal effect of
paternal exposures on offspring
outcomes may be informative.
Evidence for similar maternal and
paternal effects on offspring out-
comes is consistent with post-natal
effects of the environmental expo-
sure, whereas evidence for mater-
nal-specific effects on offspring
outcomes in the absence of (or con-
siderably weaker) paternal effects is
more consistent with prenatal
effects of the environmental expo-
sure, although maternal-specific
effects for some exposures may
reflect a stronger postnatal maternal
effect
Paternal genetic effects Paternal genotypes at the same (or correlated) SNPs
may have effects on the study exposure/outcome.
Failure to take these effects into account may re-
sult in biased estimates of the causal effect of the
maternal exposure on the offspring outcome
Include paternal genotypes in the
statistical model where possible
Low power MR studies may have low power because individual
SNPs explain small portions of variance in the ex-
posure and the outcome. This potential limitation
may be exacerbated in MR studies of maternal
exposures because the causal effect of the mater-
nal exposure on the offspring outcome may be
smaller than the effect of the maternal exposure
on maternal outcomes (as is examined in typical
MR studies)
Utilize multiple instruments that
explain more variance in the
maternal exposure
Utilize two-sample MR methods
described in this manuscript to
increase sample size and statistical
power
Violation of exclusion restriction
criteria via offspring genetic
effects on offspring outcome
Maternal SNPs may be associated with offspring
outcome via their association with offspring geno-
type violating the exclusion restriction assumption
of MR and biasing causal estimates
Perform MR analyses conditioning on
offspring genotype
Utilize two-sample MR methods
described in this manuscript
Paucity of genotyped mother–off-
spring pairs
There is a dearth of cohorts worldwide that contain
large numbers of genotyped mother–offspring
pairs for MR analyses of maternal exposures
meaning that these sorts of analyses may lack
power
Utilize two-sample MR methods
described in this manuscript to
combine summary-results
information across many
different cohorts
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Using maternal genetic effects to investigate
the effect of exposures influencing fetal
growth on future offspring health and
disease
One exposure that is of interest to the epidemiological
community is fetal growth and the in utero exposures that
influence it, and their effect on future offspring outcomes.
DOHaD posits that adverse intrauterine environments re-
sult in different fetal growth trajectories (some resulting in
growth restriction, others overgrowth) and (independently)
increased future risk of disease through developmental
changes.6 However, the in utero environment is difficult to
measure and investigators may settle with infant birth-
weight as a proxy of this. There are several problems with
this methodology, including the fact that offspring birth-
weight is an imperfect measure of growth in utero as well
as all the usual limitations of traditional observational epi-
demiological studies (confounding, etc.). We believe that
SNPs in mothers that are robustly associated with offspring
birthweight (i.e. after conditioning on offspring genotype)
exert their effects through the in utero environment and
consequently that these variants could be used to proxy in-
trauterine growth restriction. Therefore, it should be possi-
ble to use the principles of MR to investigate the causal
effect of in utero exposures influencing fetal growth on a
variety of offspring phenotypes. Specifically, we propose
that the existence of birthweight-associated SNPs in the
mother that also exert maternal genetic effects on other
offspring outcomes is highly suggestive of mechanisms con-
sistent with DOHaD.
To illustrate why this is the case, Figure 6 shows the
four credible ways in which SNPs in the mother that exert
maternal effects on offspring birthweight can also be asso-
ciated with future offspring phenotypes (although we have
used cardiometabolic disease in this example, similar dia-
grams could be used to illustrate the relationship between
in utero exposures influencing fetal growth and other off-
spring outcomes). In the different panels of this figure, we
consider the relationship between SNPs in the mother that
are associated with offspring birthweight (i.e. through ma-
ternal genetic effects) and cardiometabolic disease in the
offspring. The black ‘X’ in the diagram represents the ef-
fect of conditioning the association analysis on either the
offspring or maternal genotype and therefore blocking the
path between the conditioned genotype and the other vari-
ables of interest.
In panel (A), and consistently with DOHaD, SNPs in
mothers that produce an adverse in utero environment lead
to reduced fetal growth and subsequently lower offspring
birthweight and developmental compensations that result
in increased risk of offspring cardiometabolic disease in
later life. Under this scenario, SNPs in the maternal ge-
nome that exert maternal effects to reduce offspring birth-
weight will also be positively correlated with offspring
cardiometabolic risk (after correcting for offspring geno-
type). In panel (B), lower offspring birthweight is causal
Figure 6. This figure illustrates the four possible ways in which maternal SNPs that are associated with offspring birthweight (conditional on offspring
genotype at the same locus) can also be (unconditionally) associated with offspring cardiometabolic disease risk. The ‘X’ represents the effect of con-
ditioning the association analysis on either the offspring or maternal genotype and therefore blocking the path between the conditioned genotype
and the other variables of interest. The dashed path with the question mark indicates the potential pleiotropic effects of the offspring’s SNPs on their
own cardiometabolic disease risk.
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for increased risk of cardiometabolic disease. Under this
scenario, SNPs in the maternal genome that exert maternal
effects to reduce offspring birthweight will also be posi-
tively associated with offspring cardiometabolic disease
risk (after correcting for offspring genotype). We stress
that, although this model is broadly consistent with
DOHaD, most advocates of DOHaD would not believe
that birthweight is directly causal for future cardiometa-
bolic risk, but rather a marker of an adverse in utero envi-
ronment, as in panel (A). Nevertheless, we believe it is
important to consider this possibility, particularly as naı¨ve
MR analyses making similar assumptions have begun to
appear in the literature.33 Importantly, under panels (A)
and (B), the existence of a negative association between
maternal SNPs that are associated with lower offspring
birthweight and increases in offspring cardiometabolic
phenotypes is consistent with DOHaD.
In panel (C), the correlation between SNPs in the
mother and offspring cardiometabolic risk is driven by ge-
netic pleiotropy in the offspring genome. Under this model,
SNPs that exert maternal effects on offspring birthweight
will not be correlated with offspring cardiometabolic risk
after conditioning on offspring genotype. This model
encompasses the possibility of cardiometabolic disease-
associated SNPs in mothers directly affecting offspring
birthweight and then being transmitted to their offspring,
where they increase the risk of cardiometabolic disease in
later life.
Finally, in panel (D), SNPs that exert maternal effects
on offspring birthweight also pleiotropically influence off-
spring cardiometabolic risk through the postnatal environ-
ment. Under this model, SNPs with maternal effects on
birthweight will be associated with offspring cardiometa-
bolic risk after conditioning on offspring genotype. In gen-
eral, however, we think this last model is unlikely, since
the primary effect of these variants is likely to be on birth-
weight though the in utero environment. Any postnatal en-
vironmental effects of these variants, if they exist, on
offspring phenotypes are likely to be small in comparison
to their in utero effects. We note that the availability of
mature genotyped father–offspring pairs would provide a
test of this assumption, since we would expect that pater-
nal genotypes will not be associated with offspring cardio-
metabolic risk in the absence of postnatal environmental
effects.
Thus, the different models illustrated in Figure 6 imply
different patterns of association between maternal and
offspring SNPs, offspring birthweight and offspring cardio-
metabolic outcomes according to the source, nature
and direction of the underlying relationships. In parti-
cular, the existence of negative associations between
maternal birthweight-associated SNPs and offspring
cardiometabolic outcomes (after conditioning on offspring
genotype) strongly argues for the importance of intrauter-
ine growth restriction in this context. We therefore posit
that tests of the maternal effect of SNPs on offspring traits
(whilst conditioning on offspring genotype) are akin to
testing the validity of DOHaD in this particular context.
We note that there exist opportunities to test other models
of disease development using similar frameworks, includ-
ing the Fetal Insulin Hypothesis.12 For example, under this
hypothesis, we would predict positive relationships be-
tween maternal birthweight-associated SNPs and offspring
glycaemic variables, but negative correlations between off-
spring birthweight-associated SNPs and offspring glycae-
mic variables.
In this section, we have used birthweight SNPs to proxy
intrauterine growth restriction and have consequently
made the assumption that variation across the distribution
of birthweight is informative for inference regarding the
validity of DOHaD. Whilst utilizing birthweight-
associated SNPs represents a useful starting point for inves-
tigations, some DOHaD literature concerns the effect of
more extreme maternal exposures (e.g. famine) on fetal
growth restriction and subsequent adaptation.34 It may
well be that these sorts of exposures produce changes that
are qualitatively different from small perturbations within
the normal range. However, there is no reason why the
aforementioned methodologies could not be modified to
examine these more extreme situations. For example, it
would be interesting to investigate the effect of pre-
eclampsia on birthweight and subsequent offspring cardio-
metabolic risk. Again, a partitioning of genetic effects of
pre-eclampsia loci into maternal and offspring components
would be a necessary prerequisite for understanding the
processes involved.
Applied example
In order to illustrate the framework espoused in this manu-
script, we examined the relationship between maternal and
offspring susceptibility to type 2 diabetes and offspring
birthweight in the UK Biobank study9 (N¼ 234 154 indi-
viduals reporting their own birthweight and N¼ 210 423
mothers reporting their offspring’s birthweight). Full
details on the sample, genotyping and phenotypes are in-
cluded in the Supplementary Materials, available as
Supplementary data at IJE online. A total of 403 SNPs
identified in a recent GWAS meta-analysis of type 2 diabe-
tes35 were extracted from the imputed files provided by
UK Biobank and aligned to the type 2 diabetes risk allele
(Supplementary Table 1, available as Supplementary data
at IJE online). We fit the SEM described in Figure 1 to the
data from each of these 403 SNPs to estimate the maternal
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and offspring genetic effects on birthweight. One of the
403 SNPs, rs79046683, had a low minor allele frequency
in the UK Biobank (MAF¼ 3.910–5), so the SEM was
unable to converge using this SNP and it was therefore ex-
cluded from subsequent MR analyses. Using the effect sizes
for type 2 diabetes reported in Mahajan et al.,35 we calcu-
lated the Wald ratio estimate of the causal effect of mater-
nal susceptibility to type 2 diabetes on offspring
birthweight at each of the 402 SNPs (i.e. calculated as the
SEM-derived maternal genetic effect of the SNP on off-
spring birthweight divided by the logistic regression coeffi-
cient of the SNP association with type 2 diabetes).
Additionally, we calculated the causal effect of an individ-
ual’s own susceptibility to type 2 diabetes on their own
birthweight (i.e. calculated as the SEM-derived offspring
genetic effect of the SNP on offspring birthweight divided
by the logistic regression coefficient of the SNP association
with type 2 diabetes). Using these Wald statistics, we calcu-
lated an inverse variance-weighted (IVW) causal-effect esti-
mate, using a random-effects model for the standard error.
We also used MR Egger regression to provide estimates of
the causal effect robust to violations of the exclusion re-
striction assumption caused by horizontal pleiotropy.25
Finally, in order to compare our results to those that would
have been obtained had we not partitioned genetic effects
into maternal and offspring components using our SEM,
we generated causal-effect estimates using uncorrected esti-
mates of the SNP–own birthweight association and uncor-
rected estimates of the SNP–offspring birthweight
association using simple linear regression. Since these latter
analyses do not explicitly partition genetic effects on birth-
weight into maternal and offspring genetic components,
the SNP–birthweight associations will reflect a compli-
cated mixture of maternal and offspring genetic effects and
will likely bias downstream MR analyses.
The results of our analyses are displayed in Table 2.
We found strong evidence for a positive causal effect of
maternal susceptibility to type 2 diabetes on offspring
birthweight. In contrast, type 2 diabetes alleles transmitted
to offspring were associated with reduced birthweight.
This pattern of results was seen using both IVW MR and
MR Egger approaches and is entirely consistent with both
the Developmental Overnutrition and Fetal Insulin
Hypotheses models of the relationship between type 2 dia-
betes and birthweight.12 In short, mothers who have or are
susceptible to type 2 diabetes are likely to have poorer gly-
cemic control and higher blood glucose, resulting in
increased fetal growth and higher offspring birthweight
(Developmental Overnutrition). Conversely, children who
receive type 2 diabetes susceptibility alleles from their
parents are less sensitive to insulin and therefore tend to
have lower birthweights on average, resulting in an inverse Ta
b
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association of birthweight with subsequent type 2 diabetes
(Fetal Insulin Hypothesis).
Importantly, causal estimates obtained using the SEM-
adjusted estimates of the maternal and offspring genetic
effects were far greater in magnitude than causal estimates
obtained using the uncorrected estimates from simple lin-
ear regression. Likewise, the strength of evidence against
the null hypothesis of no association was far greater for the
SEM-derived estimates. Our results suggest that failing to
partition genetic effects into maternal and offspring genetic
components has the potential to bias the results of MR
analyses and lead to misleading interpretations of the data.
R code illustrating the SEM and two-sample MR analyses
we have performed are included in the Supplementary
Materials, available as Supplementary data at IJE online.
Future directions
We envisage that the major challenge in implementing the
ideas outlined in this manuscript will be practical rather
than technical. With some notable exceptions,5,14 most
large-scale international genetics consortia have involved
GWAS of individuals’ own genotype and phenotype. In gen-
eral, these efforts have been extraordinarily successful and
Table 3. List of cohorts that have maternal genotype data and offspring phenotype data
Cohort Approximate number of genotyped
mother–phenotyped child pairsa
1958 British Birth Cohort (B85C-T1DGC)42 8585
1958 British Birth Cohort (B85C-WTCCC)42 8365
Add Health—National Longitudinal Study of Adolescent to Adult Health43 1000
Autism Genome Project (AGP)44 259445
Avon Longitudinal Study of Parents and Children (ALSPAC)46 73045
Berlin Birth Cohort (BBC)47 13572
Born in Bradford Study (BiB)48 10 000
Chicago Food Allergy Study49 54150
Children’s Hospital of Philadelphia (CHOP) 3122
Copenhagen Prospective Study on Asthma in Childhood (COPSAC-2000)51 2822
Danish National Birth Cohort—Genomics of Young Adolescent (DNBC-GOYA)52 18055
Danish National Birth Cohort—Preterm Birth Study (DNBC-PTB)53 16565
deCODE (Genealogy Database)54 54 54613
Environmental Risk (E-Risk) Longitudinal Twin Study55 80456
Exeter Family Study of Childhood Health (EFSOCH)57 7462
Family Atherosclerosis Monitoring In earLY life (FAMILY) study58 40659
Finnish Twin Cohort60 400061
Hispanic B-cell Acute Lymphoblastic Leukemia Study62 32362
HUNT Study41 18 000
Hyperglycemia and Adverse Pregnancy Outcome Study (HAPO)63 443763
Millennium Cohort64 12 000
Minnesota Center for Twin and Family Research (MCTFR)65 140465
Netherlands Twin Register (NTR)66 7075
Northern Finland 1966 Birth Cohort Study (NFBC1966)67 20355
Norwegian Mother and Child Cohort Study (MoBa)39 46 000
Prediction and Prevention of Preeclampsia and Intrauterine Growth
Restriction Study (PREDO)68
1000
Pune Maternal Nutrition Study (PMNS)69 53369
QIMR Berghofer Cohort70 8925
Simons Simplex Collection71 257671
Sister Study72 71572
STORK Study73 52931,73
STORK Groruddalen74 634
TwinsUK75 16035
UK Biobankb,76 221 528
aThe number of genotyped mother–phenotyped child duos is based on information provided in peer-reviewed papers including on birthweight5 and gestational
weight gain,77 on the cohort’s official website or from discussions with the study principal investigators. These numbers are liable to change as more individuals
are recruited/genotyped, and should only be considered approximations.
bBirthweight only.
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responsible for the robust identification of thousands of ge-
netic loci associated with complex traits and diseases.36
Consequently, the majority of summary GWAS results data
posted on publicly available websites concern these associa-
tions. We propose the establishment of analogous interna-
tional consortia (or efforts within existing consortia) whose
remit is the detection of maternal genetic effects on offspring
phenotypes and who are committed to the deposition of
summary-results data from these collaborations on publicly
available servers and utilities such as MRBase37 and
LDHub.38 This will not only facilitate the detection of ma-
ternal genetic effects on offspring phenotypes, but also en-
able large-scale MR studies of maternal exposures and
offspring outcomes in the wider scientific community.
A logical place to start might be the establishment of
working groups focused on perinatal phenotypes, where
maternal genetic effects on offspring phenotypes are
expected to be strongest. We have already begun to do
this in the case of offspring birthweight within the EGG
consortium, where maternal genotypes and offspring phe-
notypes in the large-scale UK Biobank Study and many
other population-based birth cohorts of appreciable size
are available.5 However, many other perinatal pheno-
types have been collected by cohorts within both the EGG
and Early Genetics and Lifecourse Epidemiology
(EAGLE) consortia, which would facilitate the examina-
tion of other traits, too. There also exist several very large
Scandinavian cohorts that have maternal genotypes and
offspring outcomes, including the Norwegian Mother and
Child Cohort (MOBA),39 the HUNT Study40,41 and
DECODE13 cohorts, and several smaller twin and family
studies cohorts and family studies with parental geno-
types available that would be useful for this purpose
(Table 3).
Conclusions
Statistical methods now exist for estimating maternal ge-
netic effects on offspring phenotypes. The estimates
obtained in these studies can subsequently be used in
large-scale two-sample MR studies to investigate the
causal effect of maternal environmental exposures on off-
spring outcomes. This includes studies that aim to assess
the causal effect of in utero exposures influencing fetal
growth restriction on future risk of disease in offspring.
The establishment of large-scale international genetics
consortia geared to identifying maternal genetic effects
will assist in facilitating these sorts of studies.
Supplementary Data
Supplementary data are available at IJE online.
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